Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03507478 · ClinicalTrials.gov registry record · NA
An Evaluation of a Customized Insole to Provide Relief From Heel Pain Due to Plantar Fasciitis or General Heel Pain When Used in Footwear Over a Period of Four Weeks
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT03507478 is a NA study that has completed, run by Bayer. The registered enrollment target is 102 participants.
The verdict
NCT03507478, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The primary objective of this trial will be to demonstrate the ability of a 3/4 length foam insole to provide relief from pain due to plantar fasciitis or general heel pain when used in footwear over a 4-week period of time
Interventions
- DEVICE BPI1000013
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2018-04-10 |
| Est. Completion | 2018-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03507478
The ClinicalTrials.gov registry entry for NCT03507478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BPI1000013 is the first listed.
NCT03507478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03507478 about?
NCT03507478 is a clinical study titled "An Evaluation of a Customized Insole to Provide Relief From Heel Pain Due to Plantar Fasciitis or General Heel Pain When Used in Footwear Over a Period of Four Weeks". The primary objective of this trial will be to demonstrate the ability of a 3/4 length foam insole to provide relief from pain due to plantar fasciitis or general heel pain when used in footwear over a 4-week period of time
What is the current status of trial NCT03507478?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2018-04-10. Estimated completion is 2018-07-26.
What interventions are being tested in trial NCT03507478?
The interventions under investigation include: BPI1000013 (DEVICE).
Who is sponsoring clinical trial NCT03507478?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.